Product Images Lamivudine

The text describes a figure showing virologic response to treatment of subjects with HIV-1. The figure shows two treatment groups receiving different doses of Lamivudine. The x-axis represents treatment time in weeks while the y-axis shows the proportion of subjects with HIV-1 RNA less than 400 copies/mL. The figure indicates the percentage of responders, individuals who achieved and maintained HIV-1 RNA below 400 copies per mL at each visit, without discontinuation of treatment. The data was obtained using Roche AMPLICOR HIV-1 MONITOR assay.*

Each film-coated tablet contains 150 mg of lamivudine USP. The tablets are distributed by Aurobindo Pharma USA, Inc. and are made in India. The usual dosage and administration instructions can be found in the package insert. These tablets are prescription only and must be stored within the permitted temperature range. There is additional text related to printing zones and coding areas, but the meaning is unclear without more context.*

Lamivudine Tablets USP are a medication used to treat HIV, hepatitis B and hepatitis C infections. Each film-coated tablet contains 300 mg of amividing USP. The usual dosage and administration details can be found in the package insert. Store at a temperature between 20-25°C (68° to 77°F), with excursions permitted of 0-15° to 10-30°C (58" to B5F). The tablets come in a pack of 30 (3 X 10 Unit-dose). The manufacturer is Aurobindo Pharma USA Inc., and it is only available with a prescription.*